{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:59:27Z","timestamp":1785351567527,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.fertnstert.2024.10.040","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T20:52:08Z","timestamp":1730407928000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of letrozole in in\u00a0vitro fertilization treatment: new remedy or old mirage?"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2005-7277","authenticated-orcid":false,"given":"Nathalie","family":"B\u00fclow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Macklon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.10.040_bib1","first-page":"CD010287","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"5","author":"Franik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/GCO.0000000000000867","article-title":"The future of frozen-thawed embryo transfer in hormone replacement therapy cycles","volume":"35","author":"L\u00f8ssl","year":"2023","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib3","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib4","doi-asserted-by":"crossref","first-page":"E1524","DOI":"10.1210\/jc.2012-1427","article-title":"LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles","volume":"97","author":"Jeppesen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib5","series-title":"William textbook of endocrinology","first-page":"589","article-title":"Chapter 17 Physiology and pathology of the female reproductive axis","author":"Bulun","year":"2016"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in\u00a0vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.rbmo.2010.05.018","article-title":"The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles","volume":"21","author":"Fleming","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/molehr\/gaw070","article-title":"Inhibin-B secretion and FSH isoform distribution may play an integral part of follicular selection in the natural menstrual cycle","volume":"23","author":"Yding Andersen","year":"2017","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humrep\/deab249","article-title":"Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial","volume":"37","author":"B\u00fclow","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib11","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib12","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/del221","article-title":"Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols","volume":"21","author":"Lossl","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib13","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/cncr.10908","article-title":"An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane","volume":"95","author":"Buzdar","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib14","doi-asserted-by":"crossref","first-page":"e3633","DOI":"10.1210\/clinem\/dgac409","article-title":"The impact of suppressing estradiol during ovarian stimulation on the unsupported luteal phase: a randomized controlled trial","volume":"107","author":"Dreyer Holt","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/humrep\/deac119","article-title":"Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol","volume":"37","author":"Poulsen","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib16","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2001.19.18.3808","article-title":"Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and\/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial","volume":"19","author":"Ellis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib17","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2012.09.022","article-title":"Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer","volume":"98","author":"Reddy","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib19","first-page":"V05230315","article-title":"Letrozol I Fertilitetsbehandling","volume":"185","author":"Dahlberg","year":"2023","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0015-0282(00)01705-2","article-title":"Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate","volume":"75","author":"Mitwally","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib21","first-page":"257","article-title":"Medical and surgical treatment of reproductive outcomes in polycystic ovary syndrome: an overview of systematic reviews","volume":"13","author":"Gadalla","year":"2020","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmz035","article-title":"IUI for unexplained infertility-a network meta-analysis","volume":"26","author":"Danhof","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib23","first-page":"CD005356","article-title":"Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility","volume":"11","author":"Cantineau","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in\u00a0vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib25","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","article-title":"Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy","volume":"91","author":"Oktay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00682740","article-title":"Aromatase inhibitors\u2014mechanisms for non-steroidal inhibitors","volume":"30","author":"Vanden Bossche","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib27","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.fertnstert.2007.05.003","article-title":"Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-M\u00fcllerian hormone and inhibin-B","volume":"89","author":"Andersen","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fendo.2020.00627","article-title":"Biological and clinical rationale for androgen priming in ovarian stimulation","volume":"11","author":"L\u00f8ssl","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","article-title":"A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response","volume":"203","author":"Bastu","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/09513590.2015.1110133","article-title":"Controlled ovarian hyperstimulation with sequential letrozole co-treatment in normo\/high responders","volume":"32","author":"Ecemis","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib31","first-page":"287","article-title":"Effect of adding letrozole to gonadotropin on in\u00a0vitro fertilization outcomes: an RCT","volume":"18","author":"Eftekhar","year":"2020","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rbmo.2021.12.006","article-title":"Co-treatment with letrozole during ovarian stimulation for IVF\/ICSI: a systematic review and meta-analysis","volume":"44","author":"B\u00fclow","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102139","article-title":"Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: a meta-analysis","volume":"50","author":"Qin","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00404-022-06676-0","article-title":"Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders","volume":"306","author":"Kahraman","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib35","first-page":"101","article-title":"Impact of ovarian hyperstimulation on the luteal phase","volume":"55","author":"Macklon","year":"2000","journal-title":"J Reprod Fertil Suppl"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib36","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7827-7-40","article-title":"Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics","volume":"7","author":"Revelli","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0974-1208.142479","article-title":"Follicular steroid hormones as markers of oocyte quality and oocyte development potential","volume":"7","author":"Carpintero","year":"2014","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib39","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(16)55105-X","article-title":"Is there any correlation between follicular fluid hormone concentrations, fertilizability, and cytogenetic analysis of human oocytes recovered for in\u00a0vitro fertilization?","volume":"57","author":"Rosenbusch","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib40","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1590\/S0100-879X2004001100021","article-title":"Estradiol and testosterone concentrations in follicular fluid as criteria to discriminate between mature and immature oocytes","volume":"37","author":"Costa","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10815-020-02030-y","article-title":"Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients","volume":"38","author":"Shulman","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1933719117728800","article-title":"Ovarian stimulation in patients with cancer: impact of letrozole and BRCA mutations on fertility preservation cycle Outcomes","volume":"25","author":"Turan","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574669","article-title":"Efficacy and safety of controlled ovarian stimulation with or without letrozole co-administration for fertility preservation: a systematic review and meta-analysis","volume":"10","author":"Bonardi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib44","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/humrep\/dead182","article-title":"Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial","volume":"38","author":"B\u00fclow","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1028-4559(10)60064-2","article-title":"GnRH antagonist\/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in\u00a0vitro fertilization","volume":"49","author":"Davar","year":"2010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.rbmo.2011.05.012","article-title":"Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial","volume":"23","author":"Lee","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rbmo.2017.04.010","article-title":"High oestradiol concentration after ovarian stimulation is associated with lower maternal serum beta-HCG concentration and neonatal birth weight","volume":"35","author":"Liu","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5539\/gjhs.v8n4p166","article-title":"Comparison of GnRh agonist microdose flare up and GnRh antagonist\/letrozole in treatment of poor responder patients in intra cytoplaspic sperm injection: randomized clinical trial","volume":"8","author":"Nabati","year":"2015","journal-title":"Glob J Health Sci"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib49","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/humrep\/deac125","article-title":"Should any use of artificial cycle regimen for frozen-thawed embryo transfer in women capable of ovulation be abandoned: yes, but what\u2019s next for FET cycle practice and research?","volume":"37","author":"von Versen-H\u00f6ynck","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib50","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/humrep\/deac073","article-title":"Obstetric and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis","volume":"37","author":"Busnelli","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1530\/RAF-21-0044","article-title":"Retrospective cohort study on preparation regimens for frozen embryo transfer","volume":"2","author":"Atkinson","year":"2021","journal-title":"Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib52","article-title":"Comparison of perinatal outcomes of letrozole-induced ovulation and hormone replacement therapy protocols in patients with abnormal ovulation undergoing frozen-thawed embryo transfer: a propensity score matching analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12958-023-01154-x","article-title":"Letrozole-stimulated endometrial preparation protocol is a superior alternative to hormone replacement treatment for frozen embryo transfer in women with polycystic ovary syndrome, a cohort study","volume":"21","author":"Wang","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejogrb.2024.01.004","article-title":"What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles among anovulatory women? A retrospective cohort study","volume":"294","author":"Wen","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib55","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s10815-023-02956-z","article-title":"Letrozole use in vitrified single-blastocyst transfer cycles is associated with lower risk of large for gestational age infants in patients with polycystic ovary syndrome","volume":"40","author":"Zhang","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib56","article-title":"Comparison of pregnancy and neonatal outcomes of single frozen blastocyst transfer between letrozole-induction and HRT cycles in patients with abnormal ovulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12958-020-00675-z","article-title":"The effect of letrozole versus artificial hormonal endometrial preparation on pregnancy outcome after frozen-thawed embryos transfer cycles: a randomized clinical trial","volume":"18","author":"Hosseini-Najarkolaei","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib58","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/AOG.0000000000005367","article-title":"Letrozole during frozen embryo transfer in women with polycystic ovarian syndrome: a randomized controlled trial","volume":"142","author":"Yuan","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12978-020-01042-2","article-title":"Whether letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis","volume":"17","author":"Zhao","year":"2020","journal-title":"Reprod Health"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib61","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.fertnstert.2012.10.008","article-title":"A historical perspective of aromatase inhibitors for ovulation induction","volume":"98","author":"Casper","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib63","doi-asserted-by":"crossref","first-page":"725","DOI":"10.25122\/jml-2023-0069","article-title":"Comparing efficacy and safety of stair step protocols for clomiphene citrate and letrozole in ovulation induction for women with polycystic ovary syndrome (PCOS): a randomized controlled clinical trial","volume":"16","author":"Al-Thuwaynee","year":"2023","journal-title":"J Med Life"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib64","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.fertnstert.2005.07.230","article-title":"The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins","volume":"84","author":"Biljan","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib65","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib66","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/humupd\/dmaa055","article-title":"Risk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis","volume":"27","author":"Pundir","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.987813","article-title":"Ovulation induction regimens are associated with a higher rate of livebirth after frozen single-blastocyst transfer among women with polycystic ovary syndrome","volume":"13","author":"Niu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.10.040_bib68","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s12884-024-06795-3","article-title":"Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224023422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224023422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T01:03:47Z","timestamp":1767229427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224023422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0015028224023422"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.10.040","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of letrozole in in\u00a0vitro fertilization treatment: new remedy or old mirage?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}